(19)

(11)

EP 4 531 904 A1

(12)

(43) Date of publication: 09.04.2025 Bulletin 2025/15 (21) Application number: 23731755.7 (22) Date of filing: 25.05.2023

(51) International Patent Classification (IPC):  A61K 39/12(2006.01) C12N 15/86(2006.01) C07K 14/005(2006.01) (52) Cooperative Patent Classification (CPC): C12N 2710/10343; C12N 15/86; C12N 2770/20022; C07K 2319/735; C07K 14/005; A61K 2039/5256; A61K 2039/5258; C12N 2770/20034; A61K 39/12; A61K 2039/6075; A61K 2039/54; A61K 2039/544 (86) International application number: PCT/IB2023/055371 (87) International publication number: WO 2023/228121 (30.11.2023 Gazette 2023/48)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 25.05.2022 EP 22175424 (71) Applicant: Serum Institute of India Pvt. Ltd. Pune 411 028 (IN)	(72) Inventors: SHALIGRAM, Umesh Sharadrao Pune, 411009 (IN) NARWADE, Santosh Chandrakant Pune, 411045 (IN) (74) Representative: Weickmann & Weickmann PartmbB  Postfach 860 820 81635 München 81635 München (DE)